Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia

Abdominal or central obesity is a common morphological alteration among HIV-infected subjects on antiretroviral treatment. There is concern that this condition places the subjects at risk of cardiovascular disease. This is a cross-sectional study of 334, HIV-infected adult subjects on antiretroviral...

Full description

Bibliographic Details
Main Authors: Hejazi, Nazisa, Huang, Mary Soo Lee, Khor, Geok Lin, Lee, Christopher Kwok Choong
Format: Article
Language:English
Published: Canadian Center of Science and Education 2010
Online Access:http://psasir.upm.edu.my/id/eprint/14698/
http://psasir.upm.edu.my/id/eprint/14698/1/14698.pdf
_version_ 1848842466411675648
author Hejazi, Nazisa
Huang, Mary Soo Lee
Khor, Geok Lin
Lee, Christopher Kwok Choong
author_facet Hejazi, Nazisa
Huang, Mary Soo Lee
Khor, Geok Lin
Lee, Christopher Kwok Choong
author_sort Hejazi, Nazisa
building UPM Institutional Repository
collection Online Access
description Abdominal or central obesity is a common morphological alteration among HIV-infected subjects on antiretroviral treatment. There is concern that this condition places the subjects at risk of cardiovascular disease. This is a cross-sectional study of 334, HIV-infected adult subjects on antiretroviral therapy at a public hospital in Malaysia. It was aimed at determining the association between nutritional factors and abdominal obesity among PLHIV receiving antiretroviral treatment. Abdominal obesity was prevalent in 36.5% of the respondents. Respondents with abdominal obesity were significantly (p<0.05) older in age, had significantly higher blood triglycerides, fasting plasma glucose, lower HDL-cholesterol, higher BMI at the start of medication and also at the time of the study, bigger waist circumference, higher waist hip ratio, body fat mass, systolic and diastolic blood pressure. They also had lower mean CD4 cell count at start of medication and body lean mass than those without abdominal obesity. After adjusting for the covariates, a significant higher risk of abdominal obesity were observed in those who were older (adjusted OR=1.053, CI=1.012-1.095), had higher fasting plasma glucose (adjusted OR=1.189, CI=1.014-1.394), higher BMI at the time of study (adjusted OR=1.426, CI=1.215-1.674). Being Malay was a protective factor (adjusted OR=0.264, CI=00.102-0.685) for abdominal obesity. These results suggest that care of the HIV-infected population must include intervention to address abdominal obesity in order to provide better quality of life.
first_indexed 2025-11-15T07:59:35Z
format Article
id upm-14698
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T07:59:35Z
publishDate 2010
publisher Canadian Center of Science and Education
recordtype eprints
repository_type Digital Repository
spelling upm-146982019-04-09T03:46:22Z http://psasir.upm.edu.my/id/eprint/14698/ Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia Hejazi, Nazisa Huang, Mary Soo Lee Khor, Geok Lin Lee, Christopher Kwok Choong Abdominal or central obesity is a common morphological alteration among HIV-infected subjects on antiretroviral treatment. There is concern that this condition places the subjects at risk of cardiovascular disease. This is a cross-sectional study of 334, HIV-infected adult subjects on antiretroviral therapy at a public hospital in Malaysia. It was aimed at determining the association between nutritional factors and abdominal obesity among PLHIV receiving antiretroviral treatment. Abdominal obesity was prevalent in 36.5% of the respondents. Respondents with abdominal obesity were significantly (p<0.05) older in age, had significantly higher blood triglycerides, fasting plasma glucose, lower HDL-cholesterol, higher BMI at the start of medication and also at the time of the study, bigger waist circumference, higher waist hip ratio, body fat mass, systolic and diastolic blood pressure. They also had lower mean CD4 cell count at start of medication and body lean mass than those without abdominal obesity. After adjusting for the covariates, a significant higher risk of abdominal obesity were observed in those who were older (adjusted OR=1.053, CI=1.012-1.095), had higher fasting plasma glucose (adjusted OR=1.189, CI=1.014-1.394), higher BMI at the time of study (adjusted OR=1.426, CI=1.215-1.674). Being Malay was a protective factor (adjusted OR=0.264, CI=00.102-0.685) for abdominal obesity. These results suggest that care of the HIV-infected population must include intervention to address abdominal obesity in order to provide better quality of life. Canadian Center of Science and Education 2010 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/14698/1/14698.pdf Hejazi, Nazisa and Huang, Mary Soo Lee and Khor, Geok Lin and Lee, Christopher Kwok Choong (2010) Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia. Global Journal of Health Science, 2 (2). pp. 20-31. ISSN 1916-9736; ESSN: 1916-9744 http://www.ccsenet.org/journal/index.php/gjhs/article/view/4673 10.5539/gjhs.v2n2p20
spellingShingle Hejazi, Nazisa
Huang, Mary Soo Lee
Khor, Geok Lin
Lee, Christopher Kwok Choong
Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
title Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
title_full Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
title_fullStr Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
title_full_unstemmed Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
title_short Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
title_sort factors associated with abdominal obesity among hiv-infected adults on antiretroviral therapy in malaysia
url http://psasir.upm.edu.my/id/eprint/14698/
http://psasir.upm.edu.my/id/eprint/14698/
http://psasir.upm.edu.my/id/eprint/14698/
http://psasir.upm.edu.my/id/eprint/14698/1/14698.pdf